(BAH) Booz Allen Hamilton Holding - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US0995021062
Stock: Artificial Intelligence, Cybersecurity, Cloud Migration, Quantum Sciences
Total Rating 40
Risk 95
Buy Signal 0.00
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 2.19% |
| Yield on Cost 5y | 3.72% |
| Yield CAGR 5y | 10.42% |
| Payout Consistency | 89.1% |
| Payout Ratio | 35.7% |
| Risk 5d forecast | |
|---|---|
| Volatility | 53.7% |
| Relative Tail Risk | -23.9% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.80 |
| Alpha | -38.19 |
| Character TTM | |
|---|---|
| Beta | 0.382 |
| Beta Downside | 0.210 |
| Drawdowns 3y | |
|---|---|
| Max DD | 55.96% |
| CAGR/Max DD | -0.02 |
Description: BAH Booz Allen Hamilton Holding January 02, 2026
Booz Allen Hamilton Holding Corp. (NYSE: BAH) delivers AI-driven, cyber, and quantum technology solutions to U.S. cabinet-level agencies and commercial clients worldwide, leveraging cloud-enabled platforms, legacy system modernization, and multi-modal data fusion for intelligence, surveillance, reconnaissance, and battle-management applications.
Key operational metrics: FY 2023 revenue reached approximately $8.2 billion with a backlog of about $10.5 billion, reflecting a ~15 % year-over-year growth in AI services; the firm’s operating margin has hovered near 12 % as it scales high-margin consulting work. Sector drivers include rising federal IT and cybersecurity budgets (projected 5 % CAGR through 2028) and accelerated government investment in quantum research, which underpins demand for BAH’s post-quantum cryptography and sensing offerings.
For a deeper dive into BAH’s valuation metrics, you might explore the analysis on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income: 836.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.13 > 0.02 and ΔFCF/TA 0.86 > 1.0 |
| NWC/Revenue: 12.04% < 20% (prev 8.76%; Δ 3.28% < -1%) |
| CFO/TA 0.14 > 3% & CFO 1.02b > Net Income 836.7m |
| Net Debt (-602.0m) to EBITDA (1.13b): -0.53 < 3 |
| Current Ratio: 1.81 > 1.5 & < 3 |
| Outstanding Shares: last quarter (123.2m) vs 12m ago -3.67% < -2% |
| Gross Margin: 52.65% > 18% (prev 0.55%; Δ 5210 % > 0.5%) |
| Asset Turnover: 164.5% > 50% (prev 172.7%; Δ -8.17% > 0%) |
| Interest Coverage Ratio: 5.67 > 6 (EBITDA TTM 1.13b / Interest Expense TTM 187.1m) |
Altman Z'' 4.54
| A: 0.19 (Total Current Assets 3.08b - Total Current Liabilities 1.70b) / Total Assets 7.05b |
| B: 0.50 (Retained Earnings 3.51b / Total Assets 7.05b) |
| C: 0.15 (EBIT TTM 1.06b / Avg Total Assets 6.94b) |
| D: 0.58 (Book Value of Equity 3.48b / Total Liabilities 6.03b) |
| Altman-Z'' Score: 4.54 = AA |
Beneish M -3.09
| DSRI: 0.95 (Receivables 2.05b/2.22b, Revenue 11.41b/11.78b) |
| GMI: 1.05 (GM 52.65% / 55.04%) |
| AQI: 0.98 (AQ_t 0.52 / AQ_t-1 0.53) |
| SGI: 0.97 (Revenue 11.41b / 11.78b) |
| TATA: -0.03 (NI 836.7m - CFO 1.02b) / TA 7.05b) |
| Beneish M-Score: -3.09 (Cap -4..+1) = AA |
What is the price of BAH shares?
As of February 09, 2026, the stock is trading at USD 89.01 with a total of 1,388,774 shares traded.
Over the past week, the price has changed by +1.73%, over one month by -5.53%, over three months by +2.63% and over the past year by -28.99%.
Over the past week, the price has changed by +1.73%, over one month by -5.53%, over three months by +2.63% and over the past year by -28.99%.
Is BAH a buy, sell or hold?
Booz Allen Hamilton Holding has received a consensus analysts rating of 3.50.
Therefor, it is recommend to hold BAH.
- StrongBuy: 4
- Buy: 1
- Hold: 7
- Sell: 2
- StrongSell: 0
What are the forecasts/targets for the BAH price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 106.8 | 20% |
| Analysts Target Price | 106.8 | 20% |
| ValueRay Target Price | 87.4 | -1.8% |
BAH Fundamental Data Overview February 09, 2026
P/E Trailing = 13.2062
P/E Forward = 14.8368
P/S = 0.9616
P/B = 10.4723
P/EG = 2.29
Revenue TTM = 11.41b USD
EBIT TTM = 1.06b USD
EBITDA TTM = 1.13b USD
Long Term Debt = 3.86b USD (from longTermDebt, last quarter)
Short Term Debt = 165.0m USD (from shortTermDebt, last quarter)
Debt = 280.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -602.0m USD (from netDebt column, last quarter)
Enterprise Value = 10.37b USD (10.97b + Debt 280.0m - CCE 882.0m)
Interest Coverage Ratio = 5.67 (Ebit TTM 1.06b / Interest Expense TTM 187.1m)
EV/FCF = 11.11x (Enterprise Value 10.37b / FCF TTM 933.4m)
FCF Yield = 9.00% (FCF TTM 933.4m / Enterprise Value 10.37b)
FCF Margin = 8.18% (FCF TTM 933.4m / Revenue TTM 11.41b)
Net Margin = 7.33% (Net Income TTM 836.7m / Revenue TTM 11.41b)
Gross Margin = 52.65% ((Revenue TTM 11.41b - Cost of Revenue TTM 5.40b) / Revenue TTM)
Gross Margin QoQ = 51.95% (prev 53.63%)
Tobins Q-Ratio = 1.47 (Enterprise Value 10.37b / Total Assets 7.05b)
Interest Expense / Debt = 16.79% (Interest Expense 47.0m / Debt 280.0m)
Taxrate = 23.30% (284.0m / 1.22b)
NOPAT = 813.1m (EBIT 1.06b * (1 - 23.30%))
Current Ratio = 1.81 (Total Current Assets 3.08b / Total Current Liabilities 1.70b)
Debt / Equity = 0.27 (Debt 280.0m / totalStockholderEquity, last quarter 1.02b)
Debt / EBITDA = -0.53 (Net Debt -602.0m / EBITDA 1.13b)
Debt / FCF = -0.64 (Net Debt -602.0m / FCF TTM 933.4m)
Total Stockholder Equity = 1.02b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.06% (Net Income 836.7m / Total Assets 7.05b)
RoE = 81.85% (Net Income TTM 836.7m / Total Stockholder Equity 1.02b)
RoCE = 21.73% (EBIT 1.06b / Capital Employed (Equity 1.02b + L.T.Debt 3.86b))
RoIC = 16.29% (NOPAT 813.1m / Invested Capital 4.99b)
WACC = 7.46% (E(10.97b)/V(11.25b) * Re(7.32%) + D(280.0m)/V(11.25b) * Rd(16.79%) * (1-Tc(0.23)))
Discount Rate = 7.32% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -2.82%
[DCF Debug] Terminal Value 78.25% ; FCFF base≈897.7m ; Y1≈790.1m ; Y5≈647.9m
Fair Price DCF = 112.5 (EV 13.05b - Net Debt -602.0m = Equity 13.65b / Shares 121.3m; r=7.46% [WACC]; 5y FCF grow -14.70% → 2.90% )
EPS Correlation: 79.28 | EPS CAGR: 21.23% | SUE: 2.90 | # QB: 1
Revenue Correlation: 82.18 | Revenue CAGR: 4.29% | SUE: -1.29 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.49 | Chg30d=+0.086 | Revisions Net=+6 | Analysts=9
EPS next Year (2027-03-31): EPS=6.29 | Chg30d=+0.247 | Revisions Net=+6 | Growth EPS=+3.8% | Growth Revenue=+2.7%
P/E Forward = 14.8368
P/S = 0.9616
P/B = 10.4723
P/EG = 2.29
Revenue TTM = 11.41b USD
EBIT TTM = 1.06b USD
EBITDA TTM = 1.13b USD
Long Term Debt = 3.86b USD (from longTermDebt, last quarter)
Short Term Debt = 165.0m USD (from shortTermDebt, last quarter)
Debt = 280.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -602.0m USD (from netDebt column, last quarter)
Enterprise Value = 10.37b USD (10.97b + Debt 280.0m - CCE 882.0m)
Interest Coverage Ratio = 5.67 (Ebit TTM 1.06b / Interest Expense TTM 187.1m)
EV/FCF = 11.11x (Enterprise Value 10.37b / FCF TTM 933.4m)
FCF Yield = 9.00% (FCF TTM 933.4m / Enterprise Value 10.37b)
FCF Margin = 8.18% (FCF TTM 933.4m / Revenue TTM 11.41b)
Net Margin = 7.33% (Net Income TTM 836.7m / Revenue TTM 11.41b)
Gross Margin = 52.65% ((Revenue TTM 11.41b - Cost of Revenue TTM 5.40b) / Revenue TTM)
Gross Margin QoQ = 51.95% (prev 53.63%)
Tobins Q-Ratio = 1.47 (Enterprise Value 10.37b / Total Assets 7.05b)
Interest Expense / Debt = 16.79% (Interest Expense 47.0m / Debt 280.0m)
Taxrate = 23.30% (284.0m / 1.22b)
NOPAT = 813.1m (EBIT 1.06b * (1 - 23.30%))
Current Ratio = 1.81 (Total Current Assets 3.08b / Total Current Liabilities 1.70b)
Debt / Equity = 0.27 (Debt 280.0m / totalStockholderEquity, last quarter 1.02b)
Debt / EBITDA = -0.53 (Net Debt -602.0m / EBITDA 1.13b)
Debt / FCF = -0.64 (Net Debt -602.0m / FCF TTM 933.4m)
Total Stockholder Equity = 1.02b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.06% (Net Income 836.7m / Total Assets 7.05b)
RoE = 81.85% (Net Income TTM 836.7m / Total Stockholder Equity 1.02b)
RoCE = 21.73% (EBIT 1.06b / Capital Employed (Equity 1.02b + L.T.Debt 3.86b))
RoIC = 16.29% (NOPAT 813.1m / Invested Capital 4.99b)
WACC = 7.46% (E(10.97b)/V(11.25b) * Re(7.32%) + D(280.0m)/V(11.25b) * Rd(16.79%) * (1-Tc(0.23)))
Discount Rate = 7.32% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -2.82%
[DCF Debug] Terminal Value 78.25% ; FCFF base≈897.7m ; Y1≈790.1m ; Y5≈647.9m
Fair Price DCF = 112.5 (EV 13.05b - Net Debt -602.0m = Equity 13.65b / Shares 121.3m; r=7.46% [WACC]; 5y FCF grow -14.70% → 2.90% )
EPS Correlation: 79.28 | EPS CAGR: 21.23% | SUE: 2.90 | # QB: 1
Revenue Correlation: 82.18 | Revenue CAGR: 4.29% | SUE: -1.29 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.49 | Chg30d=+0.086 | Revisions Net=+6 | Analysts=9
EPS next Year (2027-03-31): EPS=6.29 | Chg30d=+0.247 | Revisions Net=+6 | Growth EPS=+3.8% | Growth Revenue=+2.7%